MyFinsight
Home
Blog
About
Net income
$241,400K
(-27.18%↓ Y/Y)
Deferred income taxes
-$181,300K
(-967.46%↓ Y/Y)
Accounts payable and
accrued liabilities
$123,700K
(19.29%↑ Y/Y)
Depreciation and
amortization
$42,700K
(12.07%↑ Y/Y)
Stock-based compensation
(note 10)
$42,200K
(12.53%↑ Y/Y)
Loss on impairment
(note 6)
$40,000K
(-15.07%↓ Y/Y)
Prepaid expenses and
other current assets
-$29,500K
(-312.23%↓ Y/Y)
Income taxes
$12,000K
(104.99%↑ Y/Y)
Non-cash operating lease
cost
$6,600K
(3.13%↑ Y/Y)
Net cash provided by
operating activities
$651,900K
(124.64%↑ Y/Y)
Effect of currency
exchange rate changes on...
$3,800K
(112.84%↑ Y/Y)
Canceled cashflow
$64,400K
Net (decrease)
increase in cash, cash...
$462,200K
(227.34%↑ Y/Y)
Canceled cashflow
$193,500K
Inventories
$23,500K
(156.49%↑ Y/Y)
Gain on
remeasurement of previously...
$19,900K
Other Noncash Income
Expense
$10,800K
(329.79%↑ Y/Y)
Accounts and other
receivables, net
$10,200K
(-59.04%↓ Y/Y)
Proceeds from
available-for-sale investments...
$442,600K
(-27.66%↓ Y/Y)
Proceeds from
held-to-maturity investments...
$5,900K
(-58.74%↓ Y/Y)
Issuances of notes
receivable
-$2,000K
(-103.79%↓ Y/Y)
Business combinations,
net of cash (note 7)
-$1,400K
Equity forward
contract related to...
-$100,000K
Proceeds from stock plans
$53,800K
(-5.94%↓ Y/Y)
Net cash used in
investing activities
-$193,200K
(-12.26%↓ Y/Y)
Net cash used in
financing activities
-$300K
(-100.57%↓ Y/Y)
Canceled cashflow
$451,900K
Canceled cashflow
$153,800K
Purchases of
available-for-sale investments...
$558,300K
(-10.57%↓ Y/Y)
Purchases of treasury
stock
$153,300K
(2687.27%↑ Y/Y)
Capital expenditures
$66,900K
(35.70%↑ Y/Y)
Investments in
unconsolidated affiliates
$7,100K
(-85.30%↓ Y/Y)
Other
$7,000K
(100.00%↑ Y/Y)
Purchases of
held-to-maturity investments...
$5,800K
(-3.33%↓ Y/Y)
Other
-$800K
(-180.00%↓ Y/Y)
Back
Back
Cash Flow
logo (34)-svg
Edwards Lifesciences Corp (EW)
logo (34)-svg
source: myfinsight.com
Edwards Lifesciences Corp (EW)